Plandai Biotechnology (Plandai Biotechnology) EV-to-EBITDA : -0.14 (As of Jun. 13, 2024)

Plandai Biotechnology EV-to-EBITDA Chart

Plandai Biotechnology Annual Data
	Trend	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EV-to-EBITDA		Get a 7-Day Free Trial					-3.90	-5.78	-7.28	1.53	-0.17

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EV-to-EBITDA	Get a 7-Day Free Trial											-3.90	-5.78	-7.28	1.53	-0.17

Competitive Comparison of Plandai Biotechnology's EV-to-EBITDA

For the Shell Companies subindustry, Plandai Biotechnology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plandai Biotechnology's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's EV-to-EBITDA falls into.

Plandai Biotechnology EV-to-EBITDA Calculation

Plandai Biotechnology's EV-to-EBITDA for today is calculated as:

Plandai Biotechnology's current Enterprise Value is $2.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plandai Biotechnology's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology  (OTCPK:PLPL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Plandai Biotechnology's PE Ratio for today is calculated as:

Plandai Biotechnology's share price for today is $0.0003.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plandai Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Plandai Biotechnology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Plandai Biotechnology (Plandai Biotechnology) Business Description